238 filings
Page 4 of 12
D
uj3eduw129h1k7iw50o
20 Sep 23
Indefinite amount in equity / options / securities to be acquired, sold $1.60 mm, 2 investors
5:32pm
8-K
9qf1p5l
15 Sep 23
Entry into a Material Definitive Agreement
8:45am
8-K
75zejb5vsfbdl8x84w2s
11 Aug 23
Departure of Directors or Certain Officers
8:15am
8-K
yha78vjjvbab
27 Jul 23
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives
4:01pm
8-K
2w5w6irj3f5im51bm
17 Jul 23
Other Events
5:10pm
8-K
ucz7fhfd7 uj4v7cw0dp
11 Jul 23
Entry into a Material Definitive Agreement
4:05pm
424B4
hrmmd2l
7 Jul 23
Prospectus supplement with pricing info
4:30pm
8-K
wbowpw
6 Jul 23
Allarity Therapeutics, Inc. Announces Pricing of $11 Million Public Offering
6:05am
EFFECT
9omdp
6 Jul 23
Notice of effectiveness
12:15am
8-K
z6m1r
5 Jul 23
Other Events
4:31pm
8-K
v9j scy7jlqg
30 Jun 23
Entry into a Material Definitive Agreement
4:05pm
CORRESP
vqq2q230gfilo
30 Jun 23
Correspondence with SEC
12:00am
CORRESP
a83 8rty4
30 Jun 23
Correspondence with SEC
12:00am
8-K
blg5g8cmqf
28 Jun 23
Allarity Therapeutics Announces Reverse Stock Split of
4:01pm
8-K
hq0 zeqc0a2lx
23 Jun 23
Submission of Matters to a Vote of Security Holders
5:05pm
DEFA14A
cvnn7u 762
20 Jun 23
Additional proxy soliciting materials
4:45pm
8-K
g2ohkj8w8 ug15aq
20 Jun 23
Allarity Therapeutics Announces Adjournment of Special Meeting of Stockholders
4:30pm
UPLOAD
3avfjdf5 00xk9
12 Jun 23
Letter from SEC
12:00am